Last reviewed · How we verify
COVID19 pneumonia requiring supplemental oxygen
Approved treatments
- Anakinra · Biovitrum Ab
- Kineret · Biovitrum Ab
Kineret blocks the action of interleukin-1, a protein that promotes inflammation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- COVID19 pneumonia requiring supplemental oxygen patent landscape — cliff calendar, originator estates, attackable patents
- COVID19 pneumonia requiring supplemental oxygen treatment landscape brief
- COVID19 pneumonia requiring supplemental oxygen treatment updates RSS
Frequently asked questions about COVID19 pneumonia requiring supplemental oxygen
What drugs treat COVID19 pneumonia requiring supplemental oxygen?
Tracked treatments include Anakinra, Kineret.
What is the treatment for COVID19 pneumonia requiring supplemental oxygen?
Standard treatment for COVID19 pneumonia requiring supplemental oxygen includes Anakinra, Kineret. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: COVID19 pneumonia requiring supplemental oxygen patent cliff · COVID19 pneumonia requiring supplemental oxygen CI report
- Treatment: Anakinra · Biovitrum Ab
- Treatment: Kineret · Biovitrum Ab
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing